Pharmacology
News
FDA approves new ready-to-inject glucagon product
Dasiglucagon is the third of newer-generation glucagon products that don’t require multistep reconstitution in emergency hypoglycemic situations...
News
Servier and French drug safety agency found guilty on diet drug
Servier is found guilty of “aggravated deception” for having knowingly hidden the adverse effects of Mediator for many years, but escapes the more...
News
Steroids can be stopped in some older multiple myeloma patients
Conference Coverage
National Psoriasis Foundation recommends some stop methotrexate for 2 weeks after J&J vaccine
The rationale is to optimize the antibody response to the killed-adenovirus COVID-19 vaccine.
News
First CAR T-cell therapy for multiple myeloma: Abecma
“The results of this trial represent a true turning point in the treatment of this disease.”
Conference Coverage
Denosumab now dominant therapy for osteoporosis linked to cancer
In changing patterns of osteoporosis drug prescriptions, denosumab has risen to the top of cancer indications.
Conference Coverage
Combo thyroid hormones as good as levothyroxine for hypothyroidism
In a randomized, double-blind study of three common approaches to hypothyroidism, no significant differences in symptoms were reported.
News
ApoB may better predict mortality risk in statin-treated patients
In the study, measures of apoB and non-HDL cholesterol, but not LDL cholesterol, were associated with increased residual mortality and myocardial...
News
Cannabinoids promising for improving appetite, behavior in dementia
Early evidence suggests that cannabinoids may also be beneficial for pain, sleep, and aggression.
News
Melatonin not recommended for early-stage NSCLC
There was a hint of benefit with melatonin among patients with stage III/IV NSCLC.